These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 15976463

  • 1. Visual outcomes of pan-retinal photocoagulation in diabetic retinopathy at one-year follow-up and associated risk factors.
    Rema M, Sujatha P, Pradeepa R.
    Indian J Ophthalmol; 2005 Jun; 53(2):93-9. PubMed ID: 15976463
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
    Writing Committee for the Diabetic Retinopathy Clinical Research Network, Fong DS, Strauber SF, Aiello LP, Beck RW, Callanan DG, Danis RP, Davis MD, Feman SS, Ferris F, Friedman SM, Garcia CA, Glassman AR, Han DP, Le D, Kollman C, Lauer AK, Recchia FM, Solomon SD.
    Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
    [Abstract] [Full Text] [Related]

  • 9. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
    Kaiser RS, Maguire MG, Grunwald JE, Lieb D, Jani B, Brucker AJ, Maguire AM, Ho AC, Fine SL.
    Am J Ophthalmol; 2000 Feb; 129(2):178-85. PubMed ID: 10682970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R, Sharifian E, Ghassemi F, Riazi-Esfahani M, Karkhaneh R, Fard MA, Zarei M, Modjtahedi BS, Moghimi S.
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [Abstract] [Full Text] [Related]

  • 15. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P, Mistry H, Auguste P, Shyangdan D, Freeman K, Lois N, Waugh N.
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [Abstract] [Full Text] [Related]

  • 16. Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation.
    Kleinmann G, Hauser D, Schechtman E, Landa G, Bukelman A, Pollack A.
    Int Ophthalmol; 2008 Feb; 28(1):29-34. PubMed ID: 17619829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
    Mason JO, Yunker JJ, Vail R, McGwin G.
    Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
    Nikkhah H, Ghazi H, Razzaghi MR, Karimi S, Ramezani A, Soheilian M.
    Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.